Founded in 2015, Presidio Partners focuses on investing in series B, series C, and series D rounds. They have a portfolio of companies including ESS, Wildcat Discovery Technologies, Solaria, Menlo Therapeutics, Mojo Networks, Cnano Technology, and SurgiQuest. With 11 investments and 4 exits, their most recent investment was in ESS in October 2019. They have raised a total of $142M for their venture fund, Presidio Partners 214.